Generic Name:
human insulin
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Entuzity KwikPen
Project Line:
Reimbursement Review
Project Number:
SR0672-000
NOC Status at Filing:
Post NOC
Details
Manufacturer Requested Reimbursement Criteria1:
To improve glycemic control in adults and children with diabetes mellitus requiring more than 200 units of insulin per day.
Submission Type:
Initial
Fee Schedule:
Schedule C
Indications:
To improve glycemic control in adults and children with diabetes mellitus
requiring more than 200 units of insulin per day.
Date NOC Issued:
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.